Vemurafenib
| CAS No. | 918504-65-1 |
|---|---|
| MDL No. | MFCD18074504 |
| MF | C23H18ClF2N3O3S |
| MW | 489.90 |
| InChI Key | GPXBXXGIAQBQNI-UHFFFAOYSA-N |
Pricing & Availability
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| - | - | On Request | On Request | |
| Custom synthesis and bulk supply options are available upon request. | ||||
Product Information
Vemurafenib is a pyrrolopyridine containing a 1H-pyrrolo[2,3-b]pyridine core substituted at position 5 with a p-chlorophenyl group and at position 3 with a 3-amino-2,6-difluorobenzoyl group. The amino group is condensed with propane-1-sulfonic acid to form a sulfonamide. It is a BRAF and kinase inhibitor, an antineoplastic agent, and belongs to the classes of pyrrolopyridines, sulfonamides, monochlorobenzenes, difluorobenzenes, and aromatic ketones.
| CAS No. | 918504-65-1 |
|---|---|
| Product Name | Vemurafenib |
Biological Targets
BRAF
Associated Conditions
colorectal cancer·lymphoid neoplasm·melanoma·Craniopharyngioma·hairy cell leukemia·
* The information provided here is compiled from public sources and is for reference only.
